A multi-centre, randomised, double blind, placebo-controlled trial evaluating the effects of early administration of fibrinogen concentrate in adults with major traumatic haemorrhage. E-FIT 1 Study

Trial Profile

A multi-centre, randomised, double blind, placebo-controlled trial evaluating the effects of early administration of fibrinogen concentrate in adults with major traumatic haemorrhage. E-FIT 1 Study

Completed
Phase of Trial: Phase II

Latest Information Update: 03 May 2017

At a glance

  • Drugs Fibrinogen (Primary)
  • Indications Haemorrhage
  • Focus Therapeutic Use
  • Acronyms E-FIT 1
  • Most Recent Events

    • 01 May 2017 Status changed from active, no longer recruiting to completed.
    • 11 Feb 2016 Status changed from not yet recruiting to recruiting as reported by United Kingdom Clinical Research Network record.
    • 11 Aug 2015 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top